Linear IgA/IgG bullous dermatosis after nivolumab therapy

Int J Dermatol. 2021 Aug;60(8):1007-1009. doi: 10.1111/ijd.15627. Epub 2021 Apr 26.

Authors

Héctor Perandones-González¹, Teresa Alonso-Alonso¹, Soledad Medina-Valdivieso², Rubén Linares-Navarro¹, Samuel Sáez-Álvarez³, Judith Montanchez-Mateo⁴

Affiliations

¹ Dermatology Department, Complejo Asistencial Universitario de León, Leon, Spain.
² Oncology Department, Complejo Asistencial Universitario de León, Leon, Spain.
³ Pathology Department, Complejo Asistencial Universitario de León, Leon, Spain.
⁴ Immunology Department, Complejo Asistencial Universitario de León, Leon, Spain.

PMID: 33900624
DOI: 10.1111/ijd.15627

No abstract available

Publication types

Case Reports

MeSH terms

Humans
Immunoglobulin A
Immunoglobulin G
Linear IgA Bullous Dermatosis* / chemically induced
Linear IgA Bullous Dermatosis* / diagnosis
Nivolumab* / adverse effects

Substances

Immunoglobulin A
Immunoglobulin G
Nivolumab